INT224234
From wiki-pain
|
|
|
|
|
Sentences Mentioned In
Key: | Protein | Mutation | Event | Anatomy | Negation | Speculation | Pain term | Disease term |
This can be followed by norepinephrine and epinephrine syntheses (r128r129). | |||||||||||||||
| |||||||||||||||
|
This can be followed by norepinephrine and epinephrine syntheses (r128r129). | |||||||||||||||
| |||||||||||||||
|
Hence, lysine was allowed to be taken up by neurons leading to glutamate production (r120r121) and it was degraded to acetyl-CoA (r122r124) [68,72]. | |||||||||||||||
| |||||||||||||||
|
Earlier studies of GPR17 gene expression in humans, rats and mice have shown that the receptor is primarily expressed in brain. | |||||||||||||||
| |||||||||||||||
|
It was furthermore shown that GPR17 expression was up-regulated in a rat model of ischaemic damage and that knock-down of the receptor prevented ischaemia, suggesting that GPR17 putatively could function as a mediator of brain damage (Ciana et al., 2006). | |||||||||||||||
| |||||||||||||||
|
Isoform-specific analysis of GPR17 gene expression in brain, heart and kidneys | |||||||||||||||
| |||||||||||||||
|
In order to obtain a more detailed picture of the expression pattern, using quantitative RT-PCR, we determined the relative expression levels of the two GPR17 isoforms in eight different brain regions as well as whole brain, heart and kidney. | |||||||||||||||
| |||||||||||||||
|
As hGPR17-S mainly is expressed in the brain, [35S]-GTP? | |||||||||||||||
| |||||||||||||||
|
-actin and presented relative to the normalized hGPR17-L expression in whole brain. | |||||||||||||||
| |||||||||||||||
|
Expression levels of the hGPR17 isoforms were determined in several brain regions as well as heart and kidney using quantitative RT-PCR. | |||||||||||||||
| |||||||||||||||
|
Both isoforms were expressed well with hGPR17-S being present at approximately 3040% higher levels than hGPR17-L at corresponding doses (Figure 3D). | |||||||||||||||
| |||||||||||||||
|
Thus, in the heart, hGPR17-L was expressed at approximately 12-fold higher levels than hGPR17-S. | |||||||||||||||
| |||||||||||||||
|
Given the absence of hGPR17-S expression in kidneys, the similar comparison was not applicable for this organ (Figure 2C, right).
| |||||||||||||||
| |||||||||||||||
|
In both tissues, hGPR17-L was expressed at higher levels compared with total brain (approximately seven- and twofold respectively), while the opposite was the case for hGPR17-S. | |||||||||||||||
| |||||||||||||||
|
i-coupled receptors (such as GPR17) compared with G? | |||||||||||||||
| |||||||||||||||
|
Different functional properties of GPR17 isoforms | |||||||||||||||
| |||||||||||||||
|
The cellular localization of the construct was evaluated using confocal microscopy in HEK293 cells and, as GPR17 is mainly expressed in the brain, 1321N1 astrocytoma cells. | |||||||||||||||
| |||||||||||||||
|
Notably, in two rodent models of ischaemic damage (Ciana et al., 2006; Lecca et al., 2008) and a model of spinal cord injury (Ceruti et al., 2009), GPR17 expression is up-regulated. | |||||||||||||||
| |||||||||||||||
|
In the present study, we carry out a detailed expression analysis of the two human GPR17 isoforms in a range of brain regions as well as the heart and kidney. | |||||||||||||||
| |||||||||||||||
|
Thus, in whole brain, hGPR17-S was expressed at approximately 10-fold higher levels than hGPR17-L, which was also observed in hypothalamus, cerebellar hemisphere and frontal cortex. | |||||||||||||||
| |||||||||||||||
|
General Comments
This test has worked.